For example, think of a two garden hoses, one smaller diameter and the other one larger
Hopefully, were going to see some movement in the payor coverage of these drugs in the future
However, covering this new class of medications may increase risk of premiums and claims with little known data around ROI
Think of it as a binary choice: Path A: No Training Lose 60 pounds (45 pounds fat, 15 pounds muscle) Metabolic rate drops 200+ calories daily Body composition: skinny-fat appearance Long-term: Higher regain risk, need to eat less to maintain weight Path B: Consistent Training + Protein Lose 60 pounds (55 pounds fat, 5 pounds muscle) Metabolic rate maintained or only minimal decrease Body composition: Lean, defined appearance Long-term: Lower regain risk, can eat more to maintain weight Same scale result
For example, Custer said patients who want to regulate their blood sugar could benefit from either Zepbound or retatrutide